Active Monitoring Approach for Men Aged 50 to 75 with Low Risk Prostate Cancer

What this Trial Is About

Researchers are observing men diagnosed with low-risk prostate cancer to monitor their condition over time without immediate treatment. The study focuses on using active surveillance methods to watch for any signs that the cancer may be progressing. This approach follows guidelines for patients with early-stage prostate cancer characterized by low PSA levels and specific biopsy results. The monitoring involves regular prostate-specific antigen PSA testing, digital rectal examinations DRE, transrectal ultrasounds TRUS, magnetic resonance imaging MRI, and follow-up biopsies. These tools help detect any changes in the cancer status promptly. The study tracks participants over a five-year period to evaluate cancer progression and any need for surgical treatment due to prostate enlargement causing urinary obstruction. Participants will undergo these assessments at scheduled intervals to provide detailed information about their prostate health. Researchers will use the gathered data to measure cancer progression and the occurrence of surgical interventions related to benign prostatic hyperplasia BPH. The study participation may last up to five years, during which safety and disease status are closely observed.

Active Surveillance for Low Risk Prostate Cancer